Fernandito Ruiz, in Chapmanville Wv, WV - Physical Therapist

Fernandito Ruiz, is a Physical Therapist based in Chapmanville Wv, West Virginia. Fernandito Ruiz is licensed to practice in West Virginia (license number PT000553) and his current practice location is 557 Main St, Chapmanville Wv, West Virginia. He can be reached at his office (for appointments etc.) via phone at (304) 855-4764.

NPI number for Fernandito Ruiz is 1902517998 and his current mailing address is Po Box 4304, Chapmanville, West Virginia. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1902517998.

Contact Information

	Fernandito Ruiz,
	557 Main St, Chapmanville Wv, WV 25508
	(304) 855-4764
	Not Available

Healthcare Provider's Profile

Full Name	Fernandito Ruiz
Gender	Male
Speciality	Physical Therapist
Location	557 Main St, Chapmanville Wv, West Virginia
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1902517998
Provider Enumeration Date: 12/09/2022
Last Update Date: 12/09/2022

Medical Identifiers

Medical identifiers for Fernandito Ruiz such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1902517998	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
225100000X	Physical Therapist	PT000553 (West Virginia)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Fernandito Ruiz is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Fernandito Ruiz, Po Box 4304, Chapmanville, WV 25508-4304 Ph: () -	Fernandito Ruiz, 557 Main St, Chapmanville Wv, WV 25508 Ph: (304) 855-4764

News Archive

TxCell announces five new patents for core technology and ASTrIA platform

TxCell SA, a biotech developing innovative, personalized cell-based immunotherapies using antigen-specific regulatory T-cells (Ag-Tregs) for chronic inflammatory and autoimmune diseases, today announces that five new patents for their technologies have been issued in the Unites States, Asia and Australia since the beginning of 2014.

DMPA intake may increase risk of periodontitis, gingivitis in women

Injectable progesterone contraceptives may be associated with poor periodontal health, according to research in the Journal of Periodontology. The study found that women who are currently taking depotmedroxyprogesterone acetate (DMPA) injectable contraceptive, or have taken DMPA in the past, are more likely to have indicators of poor periodontal health, including gingivitis and periodontitis, than women who have never taken the injectable contraceptive.

Study details role of dopamine in unlearning fear

Researchers at the RIKEN Center for Brain Science have discovered a circuit in the brain that is necessary for unlearning fear. Published in Nature Communications, the study details the role of dopamine in ensuring that rats stop being afraid when there isn't anything to be afraid of anymore.

Silver nanoparticles may kill beneficial bacteria

Too much of a good thing could be harmful to the environment. For years, scientists have known about silver's ability to kill harmful bacteria and, recently, have used this knowledge to create consumer products containing silver nanoparticles.

Fernandito Ruiz, - Physical Therapist in Chapmanville Wv, WV